European Equities Traded in the US as American Depositary Fall in Monday Trading

European equities traded in the US as American depositary receipts were moving lower late Monday morning, declining 0.92% to 1,284.25 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and telecommunications company VEON (VEON), which advanced 12% and 5.8% respectively. They were followed by medical device maker EDAP (EDAP) and petroleum refiner Equinor (EQNR), which rose 2.1% and 0.6% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Grifols (GRFS), which fell 12% and 4.2% respectively. They were followed by 3D printer company Materialise (MTLS) and furniture maker Natuzzi (NTZ), which were down 3% and 2.6% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which climbed 11% and 5.5% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and financial services company Lloyds Banking Group (LYG), which were up 3% and 0.2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana (NCNA) and pharmaceutical company Silence Therapeutics (SLN), which dropped 7.1% and 5.2% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which lost 3.7% and 2.9% respectively.